Alemtuzumab-induced elimination of HIV-1-infected immune cells

K Ruxrungtham, S Sirivichayakul, S Buranapraditkun, W Krause

Treatment strategies for Middle East respiratory syndrome coronavirus

Kayvon Modjarrad

HIV-1 prophylactic vaccines: state of the art

Jean-Daniel Lelièvre & Yves Lévy

Hepatitis B virus genotypes A and D in Uganda

JT Zirabamuzale, CK Opio, F Bwanga, et al.

A qualitative assessment of barriers and facilitators to ART adherence in Thai patients

M Phuphanich, M Rattanamahattana, A Avihingsanon, et al.

Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8–11 December 2015, Miami, Florida, USA

DM Margolis, K Salzwedel, N Chomont, et al.

Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C

A Hill, B Simmons, D Gotham, et al.

Treatment outcomes of first-line antiretroviral therapy in HIV-1-positive patients in Serbia

J Kušic, M Mladenovic, B Dimitrijevic, et al.

Factors associated with HIV RNA viral loads in ART-naïve patients: implications for treatment as prevention in concentrated epidemics

S Rangarajan, D Colby, G Le Truong, et al.

Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection

J Ananworanich, CP Sacdalan, S Pinyakorn, et al.

Women in HIV cure research: multilevel interventions to improve sex equity in recruitment

ME Grewe, Y Ma, A Gilbertson, et al.

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland

K Aebi-Popp, A Duppenthaler, A Rauch, et al.

Abstracts of the Seventh International Workshop on HIV Persistence during Therapy